Informed Consent in Acute Coronary Syndrome Trials

Jan 22, 2015

At what point, and under what circumstances, should trial participation be allowed to proceed without some discussion of consent? And how extensive should that discussion be? Phil Galtry and Allen Kindman of Quintiles demonstrate how this is much more than ...

Read More

Designing Mobile Solutions for Patient and Protocol

Aug 4, 2014

At a time when so many aspects of our everyday lives are influenced and enhanced by digital technology, it is clear the momentum in global mobile communications offers a huge opportunity to address some of the significant challenges  faced by the pharmaceutical industry. ...

Read More

Good Cold Chains in Clinical Trial

Aug 4, 2014

Given the increased number of global regulatory and standards-based guidance documents issued over recent years, members of the pharmaceutical supply chain are taking notice and making changes to ensure product quality and protect patient safety. Leslie Pérez Ruiz, Daymys Estévez Iglesias and ...

Read More